Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Paradi Mirmirani, a volunteer associate professor at UCSF, told SFGATE in an email that the study found hair loss was "strongest" in patients using higher doses of GLP-1s to treat obesity or for rapid weight loss but less common in patients taking lower doses of GLP-1s to treat Type 2 diabetes
Originally developed to manage diabetes, these drugs have become essential tools for weight loss
Tirzepatide (Mounjaro) is the first in its class peptide that activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
Liraglutide is similar but less effective than Ozempic
US$ 25.85
US$ 27.61
US$ 29.02
US$ 28.63
,aspect=ignore)
US$ 26.42
